Cargando…

MicroRNA miR-425 is a negative regulator of atrial natriuretic peptide

Detalles Bibliográficos
Autores principales:	Arora, Pankaj, Wu, Connie, Bloch, Donald B, Davis-Dusenbury, Brandi N, Spagnolli, Ester, Hata, Akiko, Vandenwijngaert, Sara, Swinnen, Melissa, Janssens, Stefan, Buys, Emmanuel S, Bloch, Kenneth D, Newton-Cheh, Christopher, Wang, Thomas J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Oral Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3765504/ http://dx.doi.org/10.1186/2050-6511-14-S1-O10

Ejemplares similares

MicroRNA-425 and microRNA-155 cooperatively regulate atrial natriuretic peptide expression and cGMP production
por: Vandenwijngaert, Sara, et al.
Publicado: (2018)

Human genetics, natriuretic peptides and hypertension
por: Newton-Cheh, Christopher
Publicado: (2011)

Weight Loss, Saline Loading, and the Natriuretic Peptide System
por: Arora, Pankaj, et al.
Publicado: (2015)

Cardiac soluble guanylate cyclase protects against the cardiac dysfunction induced by chronic doxorubicin treatment in mice
por: Vandenwijngaert, Sara, et al.
Publicado: (2015)

P425 Approach to identify and isolate C. dubliniensis in laboratory and comparison of various methods for same
por: Jan, Abiroo
Publicado: (2022)

What have genome-wide association studies taught us about cGMP and blood pressure regulation?
por: Newton-Cheh, Christopher
Publicado: (2013)

Associations of atrial natriuretic peptide with measures of insulin and adipose depots
por: Couch, Catharine A., et al.
Publicado: (2023)

Natriuretic peptides and fat metabolism
por: Collins, Sheila
Publicado: (2013)

FRI425 BIUXX
por: Mendonça Macedo, Daniel, et al.
Publicado: (2023)

Chronic natriuretic peptide protein therapeutics
por: Chen, Horng H, et al.
Publicado: (2013)

Genetic modifiers of hypertension in sGC-deficient mice
por: Buys, Emmanuel
Publicado: (2013)

Phenotypes of sGC mutant mice in basic conditions, disease and shock
por: Brouckaert, Peter, et al.
Publicado: (2009)

Designer natriuretic peptides for heart failure: advanced in clinical development
por: Burnett, John
Publicado: (2011)

Modulating cGMP in heart failure by novel natriuretic peptides
por: Burnett, John C
Publicado: (2009)

A novel physiological significance of natriuretic peptides in cancer metastasis
por: Kangawa, Kenji, et al.
Publicado: (2013)

Re‐evaluation of konjac gum (E 425 i) and konjac glucomannan (E 425 ii) as food additives
por: Mortensen, Alicja, et al.
Publicado: (2017)

Development of an in vivo protocol for investigating natriuretic mechanisms in response to acute sodium loading in humans
por: Phillips, LA, et al.
Publicado: (2012)

Encryptomics: how Aristotle's causality system can be applied to new molecule discovery
por: Junior, Carlos Bloch
Publicado: (2014)

Association of Common Variants in NPPA and NPPB with Circulating Natriuretic Peptides and Blood Pressure
por: Newton-Cheh, Christopher, et al.
Publicado: (2009)

The natriuretic peptide/guanylyl cyclase-A system functions as a stress-responsive regulator of angiogenesis in mice
por: Kuhn, Michaela, et al.
Publicado: (2009)

Serum aminoterminal proctype natriuretic peptide in girls with idiopathic central precocious puberty during GNRHA treatment
por: Chen, Qiu-li, et al.
Publicado: (2013)

Magnetic resonance imaging of acute and chronic atrial ablation injury - a histological validation study
por: Harrison, James, et al.
Publicado: (2013)

Regulation of MicroRNA Biogenesis: A miRiad of mechanisms
por: Davis, Brandi N, et al.
Publicado: (2009)

425 Possible Prenatal Sensitization: "The Case of the Hidden Cake"
por: Ortega Martell, José Antonio, et al.
Publicado: (2012)

MON-425 SIADH with Epistaxis: Rule out Esthesioneuroblastoma
por: Diamond, Samantha, et al.
Publicado: (2019)

Dual-IR late gadolinium enhancement achieves better blood suppression than traditional IR in a swine model of atrial radiofrequency ablation scar
por: Peel, Sarah A, et al.
Publicado: (2013)

Pharmacological preconditioning with inhaled nitric oxide (NO): Organ-specific differences in the lifetime of blood and tissue NO metabolites
por: Nagasaka, Yasuko, et al.
Publicado: (2018)

Atrial Natriuretic Peptide and Adiponectin Interactions in Man
por: Birkenfeld, Andreas L., et al.
Publicado: (2012)

Natriuretic peptides for the detection of paroxysmal atrial fibrillation
por: Seegers, Joachim, et al.
Publicado: (2015)

Awareness of atrial fibrogenesis and natriuretic peptide release
por: Meijers, W. C. F. W., et al.
Publicado: (2017)

Correction to Lancet Public Health 2020; 5: e425
Publicado: (2020)

Correction to Lancet Gastroenterol Hepatol 2020; 5: 425–27
Publicado: (2020)

Left atrial and left atrial appendage 4D blood flow dynamics in atrial fibrillation
por: Markl, Michael, et al.
Publicado: (2016)

Left atrial spherical shape change in atrial fibrillation
por: Bieging, Erik T, et al.
Publicado: (2014)

Inhibition of Bone Morphogenetic Protein Signal Transduction Prevents the Medial Vascular Calcification Associated with Matrix Gla Protein Deficiency
por: Malhotra, Rajeev, et al.
Publicado: (2015)

Efficacy of exogenous atrial natriuretic peptide in patients with heart failure with preserved ejection fraction: deficiency of atrial natriuretic peptide and replacement therapy
por: Matsumoto, Shingo, et al.
Publicado: (2020)

425. The Utility of Paired Upper and Lower COVID-19 Sampling in Patients with Artificial Airways
por: Kitt, Eimear, et al.
Publicado: (2020)

An overgrowth disorder associated with excessive production of cGMP due to a gain-of-function mutation of the natriuretic peptide receptor 2 (NPR2) gene
por: Miura, Kohji, et al.
Publicado: (2013)

Atrial natriuretic factor: is it responsible for hyponatremia and natriuresis in neurosurgery?
por: Gasparotto, Ana Paula Devite Cardoso, et al.
Publicado: (2016)

Atrial natriuretic peptide and leptin interactions in healthy men
por: Daniels, Martin A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_f0ner8jjrm51rkev36ej5463m8